Literature DB >> 12219029

The signaling protein Rho is necessary for vascular smooth muscle migration and survival but not for proliferation.

Bo Liu1, Hiroyuki Itoh, Otway Louie, Kenji Kubota, K Craig Kent.   

Abstract

BACKGROUND: The small GTPase Rho has been implicated in a variety of cellular processes. Vascular smooth muscle cell (SMC) migration, proliferation, and apoptosis are important events that contribute to the formation of intimal hyperplasia. To better understand the importance of Rho in intimal hyperplasia, we evaluated the necessity of Rho for these 3 cellular processes.
METHODS: We used for these studies a recombinant C3 exoenzyme (C3), which selectively adenosine diphosphate-ribosylates and, thus, functionally inactivates Rho. SMC migration was determined by scratch and modified Boyden chamber assays, proliferation by tritiated-thymidine incorporation, and apoptosis by terminal deoxynucleotidyl transferase-mediated dUTP nick end-labeling.
RESULTS: Pretreatment of human SMC with C3 overnight resulted in adenosine diphosphate-ribosylation and inactivation of Rho. Inactivation of Rho completely eliminated SMC migration in response to platelet-derived growth factor (PDGF)-AB. Furthermore, C3 blocked phosphorylation of focal adhesion kinase, tensin, and paxillin, which are essential for cellular migration. In contrast, C3 did not significantly affect DNA synthesis in response to PDGF-AB or activation of mitogen-activated protein kinase, a signaling mediator of PDGF-stimulated proliferation. However, prolonged inactivation of Rho by C3 induced apoptosis of SMC.
CONCLUSIONS: The small GTPase Rho is necessary for vascular SMC migration and cell survival but not for proliferation. Manipulation of Rho might have therapeutic value in modulating intimal hyperplasia.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12219029     DOI: 10.1067/msy.2002.125786

Source DB:  PubMed          Journal:  Surgery        ISSN: 0039-6060            Impact factor:   3.982


  11 in total

1.  Protein kinase C-delta regulates migration and proliferation of vascular smooth muscle cells through the extracellular signal-regulated kinase 1/2.

Authors:  Bo Liu; Evan Joseph Ryer; Rishi Kundi; Kentaro Kamiya; Hiroyuki Itoh; Peter L Faries; Kenji Sakakibara; K Craig Kent
Journal:  J Vasc Surg       Date:  2007-01       Impact factor: 4.268

2.  Phosphorylation of the cyclic AMP response element binding protein mediates transforming growth factor beta-induced downregulation of cyclin A in vascular smooth muscle cells.

Authors:  Kentaro Kamiya; Kenji Sakakibara; Evan J Ryer; Raymond P Hom; Edward B Leof; K Craig Kent; Bo Liu
Journal:  Mol Cell Biol       Date:  2007-02-26       Impact factor: 4.272

3.  Rare, nonsynonymous variant in the smooth muscle-specific isoform of myosin heavy chain, MYH11, R247C, alters force generation in the aorta and phenotype of smooth muscle cells.

Authors:  Shao-Qing Kuang; Callie S Kwartler; Katerina L Byanova; John Pham; Limin Gong; Siddharth K Prakash; Jian Huang; Kristine E Kamm; James T Stull; H Lee Sweeney; Dianna M Milewicz
Journal:  Circ Res       Date:  2012-04-17       Impact factor: 17.367

4.  Leptin augments coronary vasoconstriction and smooth muscle proliferation via a Rho-kinase-dependent pathway.

Authors:  Jillian N Noblet; Adam G Goodwill; Daniel J Sassoon; Alexander M Kiel; Johnathan D Tune
Journal:  Basic Res Cardiol       Date:  2016-03-14       Impact factor: 17.165

5.  Arterial gene transfer of the TGF-beta signalling protein Smad3 induces adaptive remodelling following angioplasty: a role for CTGF.

Authors:  Rishi Kundi; Scott T Hollenbeck; Dai Yamanouchi; Brad C Herman; Rachel Edlin; Evan J Ryer; Chunjie Wang; Shirling Tsai; Bo Liu; K Craig Kent
Journal:  Cardiovasc Res       Date:  2009-07-01       Impact factor: 10.787

6.  Characterization of primary and restenotic atherosclerotic plaque from the superficial femoral artery: Potential role of Smad3 in regulation of SMC proliferation.

Authors:  Rachel S Edlin; Shirling Tsai; Dai Yamanouchi; Chunjie Wang; Bo Liu; K Craig Kent
Journal:  J Vasc Surg       Date:  2009-05       Impact factor: 4.268

7.  TGF-beta through Smad3 signaling stimulates vascular smooth muscle cell proliferation and neointimal formation.

Authors:  Shirling Tsai; Scott T Hollenbeck; Evan J Ryer; Rachel Edlin; Dai Yamanouchi; Rishi Kundi; Chunjie Wang; Bo Liu; K Craig Kent
Journal:  Am J Physiol Heart Circ Physiol       Date:  2009-06-12       Impact factor: 4.733

8.  The cAMP-producing agonist beraprost inhibits human vascular smooth muscle cell migration via exchange protein directly activated by cAMP.

Authors:  Jenny S McKean; Fiona Murray; George Gibson; Derryck A Shewan; Steven J Tucker; Graeme F Nixon
Journal:  Cardiovasc Res       Date:  2015-06-19       Impact factor: 10.787

9.  Loss of the mechanotransducer zyxin promotes a synthetic phenotype of vascular smooth muscle cells.

Authors:  Subhajit Ghosh; Branislav Kollar; Taslima Nahar; Sahana Suresh Babu; Agnieszka Wojtowicz; Carsten Sticht; Norbert Gretz; Andreas H Wagner; Thomas Korff; Markus Hecker
Journal:  J Am Heart Assoc       Date:  2015-06-12       Impact factor: 5.501

10.  Chronic allograft rejection: A significant hurdle to transplant success.

Authors:  Malgorzata Kloc; Rafik M Ghobrial
Journal:  Burns Trauma       Date:  2014-01-26
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.